JP2010534699A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534699A5
JP2010534699A5 JP2010518590A JP2010518590A JP2010534699A5 JP 2010534699 A5 JP2010534699 A5 JP 2010534699A5 JP 2010518590 A JP2010518590 A JP 2010518590A JP 2010518590 A JP2010518590 A JP 2010518590A JP 2010534699 A5 JP2010534699 A5 JP 2010534699A5
Authority
JP
Japan
Prior art keywords
hydrogen
alkyl
formula
treatment
pediatric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010518590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534699A (ja
JP5765937B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/058601 external-priority patent/WO2009015981A2/en
Publication of JP2010534699A publication Critical patent/JP2010534699A/ja
Publication of JP2010534699A5 publication Critical patent/JP2010534699A5/ja
Application granted granted Critical
Publication of JP5765937B2 publication Critical patent/JP5765937B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010518590A 2007-08-01 2008-07-03 小児腫瘍の治療 Expired - Fee Related JP5765937B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07113603 2007-08-01
EP07113603.0 2007-08-01
PCT/EP2008/058601 WO2009015981A2 (en) 2007-08-01 2008-07-03 Treatment of pediatric tumors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014042649A Division JP2014111653A (ja) 2007-08-01 2014-03-05 小児腫瘍の治療

Publications (3)

Publication Number Publication Date
JP2010534699A JP2010534699A (ja) 2010-11-11
JP2010534699A5 true JP2010534699A5 (enExample) 2011-08-04
JP5765937B2 JP5765937B2 (ja) 2015-08-19

Family

ID=38799381

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010518590A Expired - Fee Related JP5765937B2 (ja) 2007-08-01 2008-07-03 小児腫瘍の治療
JP2014042649A Ceased JP2014111653A (ja) 2007-08-01 2014-03-05 小児腫瘍の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014042649A Ceased JP2014111653A (ja) 2007-08-01 2014-03-05 小児腫瘍の治療

Country Status (11)

Country Link
US (1) US8829021B2 (enExample)
EP (1) EP2182951A2 (enExample)
JP (2) JP5765937B2 (enExample)
KR (1) KR20100051837A (enExample)
CN (1) CN101784277A (enExample)
BR (1) BRPI0815051A2 (enExample)
CA (1) CA2694389C (enExample)
EA (1) EA015933B1 (enExample)
MX (1) MX2010001084A (enExample)
SG (1) SG183010A1 (enExample)
WO (1) WO2009015981A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2912193T (lt) 2012-10-29 2018-12-27 Arizona Board Of Regents On Behalf Of University Of Arizona Prognozuojami žymenys, skirti vėžio terapijoms poliamino inhibitoriumi
JP2017519770A (ja) 2014-06-18 2017-07-20 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティ オブ アリゾナ Odc1遺伝子型に基づく癌腫の診断および処置
HK1248133A1 (zh) * 2015-02-12 2018-10-12 The Arizona Board Of Regents On Behalf Of The University Of Arizona 治疗神经母细胞瘤的方法
HK1258284A1 (zh) 2015-10-30 2019-11-08 癌症预防制药股份有限公司 依氟鸟氨酸和舒林酸,固定剂量的组合制剂
WO2020236562A1 (en) 2019-05-17 2020-11-26 Cancer Prevention Pharmaceuticals, Inc. Methods for treating familial adenomatous polyposis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1044977B1 (en) * 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
AU2006328607B2 (en) * 2005-12-21 2012-04-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Treatment of drug-resistant tumors
US8853233B2 (en) * 2007-02-13 2014-10-07 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives

Similar Documents

Publication Publication Date Title
JP2015505296A5 (enExample)
JP2007302689A5 (enExample)
JP2010529147A5 (enExample)
JP2013518107A5 (enExample)
JP2009242409A5 (enExample)
JP2014506907A5 (enExample)
JP2015537020A5 (enExample)
JP2012255026A5 (enExample)
JP2013542247A5 (enExample)
JP2008533007A5 (enExample)
JP2009507909A5 (enExample)
JP2013032389A5 (enExample)
JP2012519182A5 (enExample)
RU2015109132A (ru) Пролекарственная форма тенофовира и ее фармацевтические применения
JP2009235100A5 (enExample)
JP2010529118A5 (enExample)
JP2010138190A5 (enExample)
JP2011246469A5 (enExample)
JP2010534699A5 (enExample)
JP2009506014A5 (enExample)
JP2013514980A5 (enExample)
JP2012512863A5 (enExample)
JP2013533253A5 (enExample)
JP2013542981A5 (enExample)
JP2010090149A5 (enExample)